益方生物：预计2025年净亏损2.92亿元

Core Viewpoint - The company expects a net profit attributable to the parent company of -292 million yuan for the fiscal year 2025, indicating continued financial challenges ahead [1] Financial Performance - The company anticipates achieving an operating revenue of 37.2452 million yuan in 2025, which suggests a significant struggle to reach profitability [1] - The expected losses in 2025 are primarily influenced by the intensity of research and development investments alongside the composition of revenue [1]